AKT1 and autoimmune thrombocytopenic purpura: For example, eltrombopag, a nonpeptide thrombopoietin receptor agonist used for ITP, induced immature MK proliferation rather than platelet production through the unbalanced activation of AKT and ERK1/2 signaling molecules [27].